PAPAVERINE HCL
VASODILATORS · CEREBRAL ISCHEMIA ·+1
American Regent
Drug class
Peripheral Vasodilators
Peripheral vasodilators are a broad pharmacological class of medications that act directly or indirectly on vascular smooth muscle to widen peripheral blood vessels and decrease vascular resistance. Read more about Peripheral Vasodilators
5 drugs in this class 5 manufacturers
Drugs in Peripheral Vasodilators
ERGOLOID MESYLATES
CEREBRAL VASODILATORS · DEMENTIA
MUTUAL PHARM CO
PAPAVERINE HCL
VASODILATORS · CEREBRAL ISCHEMIA ·+1
NEXUS PHARMACEU
PAPAVERINE HCL
VASODILATORS · CEREBRAL ISCHEMIA ·+1
BPI LABS, LLC
PAPAVERINE HCL
VASODILATORS · CEREBRAL ISCHEMIA ·+1
ORYZA PHARMACEU
Filter & compare in the drug finder →
Opens the drug finder with Peripheral Vasodilators preselected. Add indication or manufacturer filters there.
Peripheral vasodilators are a broad pharmacological class of medications that act directly or indirectly on vascular smooth muscle to widen peripheral blood vessels and decrease vascular resistance.
By promoting arterial or venous relaxation and enhancing microcirculatory perfusion, these agents improve regional blood flow and reduce cardiac afterload.
In clinical practice, drugs categorized under this therapeutic grouping are predominantly utilized in the management of severe or refractory hypertension, peripheral arterial disease, intermittent claudication, and vasospastic conditions such as Raynaud phenomenon.
-
fda.gov
Peripheral vasodilators are a broad pharmacological class of medications that act directly or indirectly on vascular smooth muscle to widen peripheral blood vessels and decrease vascular resistance By promoting arterial or venous relaxation and enhancing microcirculatory perfusion, these agents improve regional blood flow and reduce cardiac afterload In clinical practice, drugs categorized under this therapeutic grouping are predominantly utilized in the management of severe or refractory hypert...
-
fda.gov
Peripheral vasodilators are a broad pharmacological class of medications that act directly or indirectly on vascular smooth muscle to widen peripheral blood vessels and decrease vascular resistance
-
fda.gov
By promoting arterial or venous relaxation and enhancing microcirculatory perfusion, these agents improve regional blood flow and reduce cardiac afterload
-
medlineplus.gov
In clinical practice, drugs categorized under this therapeutic grouping are predominantly utilized in the management of severe or refractory hypertension, peripheral arterial disease, intermittent claudication, and vasospastic conditions such as Raynaud phenomenon
-
nih.gov
In clinical practice, drugs categorized under this therapeutic grouping are predominantly utilized in the management of severe or refractory hypertension, peripheral arterial disease, intermittent claudication, and vasospastic conditions such as Raynaud phenomenon
-
nih.gov
In clinical practice, drugs categorized under this therapeutic grouping are predominantly utilized in the management of severe or refractory hypertension, peripheral arterial disease, intermittent claudication, and vasospastic conditions such as Raynaud phenomenon
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.